Font Size:
Orchid Buys Karalex Pharma for Generics Marketing Presence in the US
Heather Cartwright
Abstract
Orchid Chemicals & Pharmaceuticals has established a direct marketing facility in the US for its generic products by acquiring Karalex Pharma, a US-based generic marketing and sales service provider.
Add comment
This work is licensed under a Creative Commons Attribution 3.0 License.